Dewpoint Slashes Headcount by 70% as Cash Runway Runs Out
In December 2024, Dewpoint Therapeutics CEO Ameet Nathwani said the biotech’s cash runway would last until the third quarter of 2025.
Dewpoint Slashes Headcount by 70% as Cash Runway Runs Out Read More »
